PRIG
PFE icon

Payden & Rygel Investment Group’s Pfizer PFE Stock Holding History

Payden & Rygel Investment Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$839K Sell
29,980
-240,400
-89% -$6.62M 0.07% 88
2024
Q1 		$7.5M Buy
+270,380
New +$7.5M 0.35% 77
2023
Q3 		$994K Buy
+29,980
New +$1.06M 0.07% 97

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Payden & Rygel Investment Group's PFE Position: Q2 2024 in Review

Payden & Rygel Investment Group reduced its Pfizer (PFE) stake by 89% in Q2 2024, selling an estimated $6.62M and leaving 29,980 shares worth $839K. The position accounts for 0.07% of the portfolio, ranked #88.

Payden & Rygel Investment Group first reported a position in PFE in Q3 2023 and has held it in 3 quarters since. The position peaked at $7.5M in Q1 2024. 2,873 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

  • Payden & Rygel Investment Group held 29,980 shares of Pfizer worth $839K as of Q2 2024.
  • Payden & Rygel Investment Group sold 240,400 Pfizer shares in Q2 2024, an estimated $6.62M.
  • Pfizer made up 0.07% of Payden & Rygel Investment Group's portfolio in Q2 2024, its #88 holding.
  • Payden & Rygel Investment Group first reported a position in Pfizer in Q3 2023 and has held it in 3 quarters since.
  • Payden & Rygel Investment Group's Pfizer position peaked at $7.5M in Q1 2024.
  • 2,873 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on Payden & Rygel Investment Group's 13F filing for Q2 2024, filed 12 Aug 2024.